Asset Management Company — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Chimerixchimerix.com 𝕏Jul 2019

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical DevicesDurham, US

Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)

Co-investorsAisling Capital Alta Partners Canaan Partners Frazier Life Sciences Pappas Capital Sanderling Ventures

Unnatural Productsunnaturalproducts.com in 𝕏Sep 2019

Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US

Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in

BoardVasudev Bailey(Director)in

Co-investorsAbstract Ventures Artis Ventures Better Ventures Central Llc Blue Bear Ventures Colorcon Ventures Droia Ventures +9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.